Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Baker, Virginia S ^a,f   Imade, Godwin E ^b   Molta, Norman B ^b   Tawde, Pallavi ^a   Pam, Sunday D ^b   Obadofin, Michael O ^b   Sagay, Soloman A ^b   Egah, Daniel Z ^b   Iya, Daniel ^b   Afolabi, Bangmboye B ^c   Baker, Murray ^d   Ford, Karen ^e   Ford, Robert ^e   Roux, Kenneth H ^a   Keller III, Thomas C S ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF JOS   (Nigeria)

^c NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^d Jackson Hospital   (United States)

^e World Health Mission   (United States)

^f Chipola Junior College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; DOUBLE STRANDED DNA; FANSIDAR; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; CYTOKINE; IMMUNOGLOBULIN G;

ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; BLOOD SMEAR; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHROCYTE ADHESIVENESS; EXTRACELLULAR SPACE; GIEMSA STAIN; HUMAN; IMMUNOASSAY; LEUKOCYTE DIFFERENTIAL COUNT; MALARIA; NEUTROPHIL; PARASITE TRANSMISSION; PATHOGENESIS; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; TH2 CELL; ANIMAL; BLOOD; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKOCYTE COUNT; MALARIA FALCIPARUM; NIGERIA;

ANIMALS; ANTIBODIES, ANTINUCLEAR; CHILD, PRESCHOOL; CYTOKINES; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTE COUNT; MALARIA, FALCIPARUM; NEUTROPHILS; NIGERIA; PLASMODIUM FALCIPARUM;

EID: 42949163069     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-41     Document Type: Article

References (68)

1. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. MF Good H Xu M Wykes CR Engwerda, Annu Rev Immunol 2005 23 69 99 10.1146/annurev.immunol.23.021704. 115638 15771566
2. The immune response to Plasmodium falciparum malaria. L Malaguarnera S Musumeci, Lancet Infect Dis 2002 2 472 478 10.1016/S1473-3099(02)00344-4 12150846
3. Innate immunity to malaria. MM Stevenson EM Riley, Nat Rev Immunol 2004 4 169 180 10.1038/nri1311 15039754
4. Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. OR Millington C Di Lorenzo RS Phillips P Garside JM Brewer, J Biol 2006 5 5 16611373 10.1186/jbiol34
5. Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria. V Nussenblatt G Mukasa A Metzger G Ndeezi E Garrett RD Semba, Clin Diagn Lab Immunol 2001 8 1164 1170 11687458 10.1128/CDLI.8.6.1164- 1170.2001
6. Genomewide analysis of the host response to malaria in Kenyan children. MJ Griffiths MJ Shafi SJ Popper CA Hemingway MM Kortok A Wathen KA Rockett R Mott M Levin CR Newton K Marsh DA Relman DP Kwiatkowski, J Infect Dis 2005 191 1599 1611 10.1086/429297 15838786
7. Comparative folate metabolism in humans and malaria parasites (part II): activities as yet untargeted or specific to Plasmodium. A Nzila SA Ward K Marsh PF Sims JE Hyde, Trends Parasitol 2005 21 334 339 10.1016/j.pt.2005.05.008 15936248
8. Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy. A Nzila SA Ward K Marsh PF Sims JE Hyde, Trends Parasitol 2005 21 292 298 10.1016/j.pt.2005.04.002 15922251
9. Hyperhomocysteinemia in acute Plasmodium falciparum malaria: an effect of host-parasite interaction. R Chillemi B Zappacosta J Simpore S Persichilli M Musumeci S Musumeci, Clin Chim Acta 2004 348 113 120 10.1016/j.cccn.2004.05.007 15369744
10. Mechanisms of resistance of malaria parasites to antifolates. A Gregson CV Plowe, Pharmacol Rev 2005 57 117 145 10.1124/pr.57.1.4 15734729
11. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. A Many L Schreiber S Rosner JB Lessing A Eldor MJ Kupferminc, Obstet Gynecol 2001 98 1041 1044 10.1016/S0029-7844(01)01621-0 11755551
12. Oxidant-antioxidant system changes relative to placental-umbilical pathology in patients with preeclampsia. E Bulgan Kilicdag G Ay A Celik B Ustundag I Ozercan M Simsek, Hypertens Pregnancy 2005 24 147 157 10.1081/PRG-200059863 16036399
13. Hemozoin differentially regulates proinflammatory cytokine production in human immunodeficiency virus-seropositive and -seronegative women with placental malaria. JM Moore S Chaisavaneeyakorn DJ Perkins C Othoro J Otieno BL Nahlen YP Shi V Udhayakumar, Infect Immun 2004 72 7022 7029 15557625 10.1128/IAI.72.12. 7022-7029.2004
14. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. E Llurba E Gratacos P Martin-Gallan L Cabero C Dominguez, Free Radic Biol Med 2004 37 557 570 10.1016/j.freeradbiomed.2004. 04.035 15256227
15. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. S Muller, Mol Microbiol 2004 53 1291 1305 10.1111/j.1365-2958.2004. 04257.x 15387810
16. Oxidative stress in patients with non-complicated malaria. A Pabon J Carmona LC Burgos S Blair, Clin Biochem 2003 36 71 78 10.1016/S0009-9120(02) 00423-X 12554064
17. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. PR Taylor A Carugati VA Fadok HT Cook M Andrews MC Carroll JS Savill PM Henson M Botto MJ Walport, J Exp Med 2000 192 359 366 10.1084/jem.192.3.359 10934224
18. Loss of red blood cell-complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia. JA Stoute AO Odindo BO Owuor EK Mibei MO Opollo JN Waitumbi, J Infect Dis 2003 187 522 525 10.1086/367712 12552440
19. Complement activation by necrotic cells in normal plasma environment compares to that by late apoptotic cells and involves predominantly IgM. CL Ciurana B Zwart G van Mierlo CE Hack, Eur J Immunol 2004 34 2609 2619 10.1002/eji.200425045 15307193
20. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation. J Dernellis M Panaretou, Am J Cardiol 2006 97 245 248 10.1016/j.amjcard.2005.08.027 16442371
21. Protective Molecules-C-Reactive Protein (CRP), Serum Amyloid P (SAP), Pentraxin3 (PTX3), Mannose-Binding Lectin (MBL), and Apolipoprotein A1 (Apo A1), and Their Autoantibodies: Prevalence and Clinical Significance in Autoimmunity. MS Kravitz M Pitashny Y Shoenfeld, J Clin Immunol 2005 25 582 591 10.1007/s10875-005-7828-2 16380821
22. Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q. LT Roumenina AA Kantardjiev BP Atanasov P Waters M Gadjeva KB Reid A Mantovani U Kishore MS Kojouharova, Biochemistry 2005 44 14097 14109 10.1021/bi051186n 16245926
23. C-reactive protein upregulates complement-inhibitory factors in endothelial cells. SH Li PE Szmitko RD Weisel CH Wang PW Fedak RK Li DA Mickle S Verma, Circulation 2004 109 833 836 10.1161/01.CIR.0000117087.27524.0E 14967730
24. Is there a role for autoimmunity in immune protection against malaria? CT Daniel-Ribeiro, Mem Inst Oswaldo Cruz 2000 95 199 207 10733739
25. Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria. SC Chaiyaroj AS Rutta K Muenthaisong P Watkins M Na Ubol S Looareesuwan, Acta Trop 2004 89 319 327 10.1016/j.actatropica.2003.10.010 14744558
26. Cerebral malaria - a neurovascular pathology with many riddles still to be solved. N Coltel V Combes NH Hunt GE Grau, Curr Neurovasc Res 2004 1 91 110 10.2174/1567202043480116 16185187
27. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. DK Dalton L Haynes CQ Chu SL Swain S Wittmer, J Exp Med 2000 192 117 122 10.1084/jem.192.1.117 10880532
28. Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria. MJ Griffiths F Ndungu KL Baird DP Muller K Marsh CR Newton, Br J Haematol 2001 113 486 491 10.1046/j.1365-2141.2001.02758.x 11380421
29. Cytokine profile suggesting that murine cerebral malaria is an encephalitis. VM Jennings JK Actor AA Lal RL Hunter, Infect Immun 1997 65 4883 4887 9353082
30. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. P Kern CJ Hemmer J Van Damme HJ Gruss M Dietrich, Am J Med 1989 87 139 143 2667356
31. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. JA Kurtzhals V Adabayeri BQ Goka BD Akanmori JO Oliver-Commey FK Nkrumah C Behr L Hviid, Lancet 1998 351 1768 1772 10.1016/S0140-6736(97)09439-7 9635949
32. Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J May B Lell AJ Luty CG Meyer PG Kremsner, J Infect Dis 2000 182 1570 1573 10.1086/315857 11023485
33. Increased levels of interleukin-12 in Plasmodium falciparum malaria: correlation with the severity of disease. L Malaguarnera RM Imbesi S Pignatelli J Simpore M Malaguarnera S Musumeci, Parasite Immunol 2002 24 387 389 10.1046/j.1365-3024.2002.00478.x 12164825
34. Progress in understanding the pathogenesis of the anemia of chronic disease. RT Means Jr. SB Krantz, Blood 1992 80 1639 1647 1391934
35. TGF-beta1 released from activated platelets can induce TNF-stimulated human brain endothelium apoptosis: a new mechanism for microvascular lesion during cerebral malaria. SC Wassmer JB de Souza C Frere FJ Candal I Juhan-Vague GE Grau, J Immunol 2006 176 1180 1184 16394007
36. Brain gene expression, metabolism, and bioenergetics: interrelationships in murine models of cerebral and noncerebral malaria. C Rae JA McQuillan SB Parekh WA Bubb S Weiser VJ Balcar AM Hansen HJ Ball NH Hunt, Faseb J 2004 18 499 510 10.1096/fj.03-0543com 15003995
37. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. AK Gupta P Hasler W Holzgreve S Gebhardt S Hahn, Hum Immunol 2005 66 1146 1154 10.1016/j.humimm. 2005.11.003 16571415
38. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. CF Urban U Reichard V Brinkmann A Zychlinsky, Cell Microbiol 2006 8 668 676 10.1111/j.1462-5822.2005.00659.x 16548892
39. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. N Festjens T Vanden Berghe P Vandenabeele, Biochim Biophys Acta 2006 1757 1371 1387 10.1016/j.bbabio.2006. 06.014 16950166
40. Novel cell death program leads to neutrophil extracellular traps. TA Fuchs U Abed C Goosmann R Hurwitz I Schulze V Wahn Y Weinrauch V Brinkmann A Zychlinsky, J Cell Biol 2007 176 231 241 17210947 10.1083/jcb.200606027
41. Cell death by necrosis: towards a molecular definition. P Golstein G Kroemer, Trends Biochem Sci 2007 32 37 43 10.1016/j.tibs.2006.11.001 17141506
42. Neutrophil extracellular traps kill bacteria. V Brinkmann U Reichard C Goosmann B Fauler Y Uhlemann DS Weiss Y Weinrauch A Zychlinsky, Science 2004 303 1532 1535 10.1126/science.1092385 15001782
43. DNA vaccines: a key for inducing long-term cellular immunity. S Gurunathan CY Wu BL Freidag RA Seder, Curr Opin Immunol 2000 12 442 447 10.1016/S0952-7915(00)00118-7 10899026
44. CpG oligodeoxynucleotides enhance FcgammaRI-mediated cross presentation by dendritic cells. L Bevaart HH Van Ojik AW Sun TH Sulahian JH Leusen GJ Weiner JG Van De Winkel MJ Van Vugt, Int Immunol 2004 16 1091 1098 10.1093/intimm/dxh110 15192052
45. Socio-economic factors responsible for poor utilisation of the primary health care services in a rural community in Nigeria. PY Katung, Niger J Med 2001 10 28 29 11705051
46. Responses of Plasmodium falciparum infections to antimalarial drugs in north eastern Nigeria - Part 1: 1988-1995. NB Molta IM Watila S Ogucho, Journal of Pharmacy and Bioresources 2004 1 51 60
47. African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death. D Schellenberg C Menendez E Kahigwa F Font C Galindo C Acosta JA Schellenberg JJ Aponte J Kimario H Urassa H Mshinda M Tanner P Alonso, Am J Trop Med Hyg 1999 61 431 438 10497986
48. Manual of Infection Prevention and Control Policies and Guidelines. WHO/AFRO, Harare, Zimbabwe, World Health Organization Regional Office for Africa 2001
49. [Megakaryocyte ploidy in patients with myelodysplastic syndrome - by microcytofluorometry with DAPI staining after removal of Wright-Giemsa staining]. Y Kobayashi M Ozawa N Maruo M Kondo, Rinsho Ketsueki 1989 30 1915 1922 2481752
50. A color atlas and instruction manual of peripheral cell morphology. BH O'Conner, Philadelphia, Lippincott Williams & Wilkins 1984
51. Clinical Hematology. DM Harmening, Philadelphia, F.A. Davis Company 4th 2002 12406988
52. Image Library - Malaria. DP Diseases, http://www.dpd.cdc.gov/dpdx/HTML/ ImageLibrary/Malaria_il.htm
53. How do microbes evade neutrophil killing? CF Urban S Lourido A Zychlinsky, Cell Microbiol 2006 8 1687 1696 10.1111/j.1462-5822.2006.00792.x 16939535
54. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. JT Buchanan AJ Simpson RK Aziz GY Liu SA Kristian M Kotb J Feramisco V Nizet, Curr Biol 2006 16 396 400 10.1016/j.cub.2005.12.039 16488874
55. The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. NF Rothfield BD Stollar, J Clin Invest 1967 46 1785 1794 4168731
56. Antibodies to DNA. BH Hahn, N Engl J Med 1998 338 1359 1368 10.1056/NEJM199805073381906 9571257
57. Clinical significance of antinuclear antibodies. NF Rothfield, J Med Assoc Ga 1967 56 491 494 4866469
58. Prevention and treatment of hyperuricemia in hematological malignancies. MS Cairo, Clin Lymphoma 2002 3 Suppl 1 S26 31 12521386
59. Regulation of nitric oxide synthesis in uraemia. M Arese M Strasly C Ruva C Costamagna D Ghigo R MacAllister G Verzetti C Tetta A Bosia F Bussolino, Nephrol Dial Transplant 1995 10 1386 1397 8538931
60. Allopurinol in the therapy of neoplasia and blood diseases. Metabolic aspects. RW Watts, Ann Rheum Dis 1966 25 657 659 5226512
61. Anaemia of Plasmodium falciparum malaria. RE Phillips G Pasvol, Baillieres Clin Haematol 1992 5 315 330 1511178
62. Plasmodium falciparum induces apoptosis in human mononuclear cells. A Toure-Balde JL Sarthou G Aribot P Michel JF Trape C Rogier C Roussilhon, Infect Immun 1996 64 744 750 8641776
63. Regulation of phagocytic leukocyte activities by C-reactive protein. RF Mortensen W Zhong, J Leukoc Biol 2000 67 495 500 10770281
64. CRP after 2004. A Agrawal, Mol Immunol 2005 42 927 930 10.1016/j.molimm.2004.09.028 15829284
65. Levels of phosphor-Smad2/3 are sensors of the interplay between effects of TGF-B and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells. C Zhouhong KC Flanders D Bertolette L LA W JU P WT L JJ R FW R AB, Blood 2003 101 498 507 10.1182/blood-2002-05-1549 12393416
66. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. M Torzewski C Rist RF Mortensen TP Zwaka M Bienek J Waltenberger W Koenig G Schmitz V Hombach J Torzewski, Arterioscler Thromb Vasc Biol 2000 20 2094 2099 10978254
67. DNA vaccines: immunology, application, and optimization*. S Gurunathan DM Klinman RA Seder, Annu Rev Immunol 2000 18 927 974 10.1146/annurev.immunol.18.1.927 10837079
68. Toll-like receptors in innate immunity. K Takeda S Akira, Int Immunol 2005 17 1 14 10.1093/intimm/dxh186 15585605